Show All
Where and when was Milestone Pharmaceuticals incorporated?
Milestone Pharmaceuticals was incorporated in Québec in 2003.
Where is Milestone Pharmaceuticals headquartered?
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montréal, Québec CA H4M 2X6.
When did Milestone Pharmaceuticals go public?
Milestone’s common shares first started trading on the Nasdaq Global Select Market on May 9, 2019.
On which exchange is Milestone Pharmaceuticals listed and what is the ticker symbol?
Milestone’s common shares are traded on The Nasdaq Global Select Market under the symbol “MIST.”
Who is Milestone’s transfer agent and how do I contact them?
Milestone’s transfer agent is Computershare Investor Services Inc. Please see below for the transfer agent contact information:

Computershare Investor Services Inc.
1500, boulevard Robert-Bourassa, 7e étage
Montréal (Québec) H3A 3S8
How can I purchase shares?
Shares can be purchased through any registered broker.
Does Milestone Pharmaceuticals pay dividends and have a dividend reinvestment program?
Currently, Milestone Pharmaceuticals does not pay dividends or offer a dividend reinvestment program.
What is Milestone’s CUSIP number?
What is Milestone’s fiscal year-end?
Milestone’s fiscal year-end is December 31st.
Who are Milestone’s independent auditors?
PricewaterhouseCoopers LLP.
Where can I find recent Milestone’s press releases?
You can view our recent press releases by visiting the News & Events section of our website.
How can I sign up to receive Milestone’s press releases and other company information?
Please visit the Investor Resources section of our website and choose the Email Alerts button to be added to the Milestone distribution list.
How can I view documents Milestone Pharmaceuticals has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Information section of our Investor & Media website page or directly from the SEC at www.sec.gov.
If I have questions regarding Milestone Pharmaceuticals that have not been answered, whom should I contact?
Investor relations inquiries may be submitted inquiries to ir@milestonepharma.com.
Print Page
RSS Feeds
Email Alerts
Investor Contact